Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the creation of stereoselective drug candidates, especially in the design of enzyme inhibitors or receptor modulators. The fluorophenyl group enhances binding affinity in biological systems, making it valuable in medicinal chemistry for optimizing pharmacokinetic properties. Commonly employed in research settings for constructing complex pyrrolidine-based scaffolds with potential therapeutic activity.